Through MR analysis of these complications, we examined the effects of three common cholesterol-lowering drug targets (HMGCR, PCSK9, and NPC1L1) on three major diabetic microvascular complications: diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. The gene discussed is NPC1L1; the disease is diabetic kidney disease.